Back to Authors

group, INSIGHT START study

Mayo Clinic

No affiliation available

Citations 1

Risk of Suicidal Behavior With Use of Efavirenz: Results from the Strategic Timing of Antiretroviral Treatment Trial

Clinical Infectious Diseases | February 1, 2018 | Volume: 67 | Issue: 3 | Pages: 420-429

10.1093/cid/ciy051 | PMID 29538636